Considering a broader global view of the life sciences industry, 2018 was another strong-performing year for M&A activity, where with the UK specifically, key highlights include:
– The total number of UK life sciences vacancies rose by 20%.
– CRO’s have grown significantly over 2018, with activity up over 25%. IQVIA specifically has seen a large increase.
– Finally, vacancies for clinical roles have seen a 40% rise over 2018, with clinical projects being a key area.